Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 32706 participants.
Also called NCT05932472
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 32,706 participants
- Sponsor
- Registry
-
NCT05932472
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT05932472. Randomized; no masking; primary purpose treatment. Start 2024-01-15 (actual); primary completion 2027-01-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial
- Acronym
- ASPIRIN-C3
- Condition
- Atherosclerosis
- Condition
- Cardiovascular Diseases
- Condition
- Drug Effect
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Tor Biering-Sørensen
Record details
- Record id
cardio:ct-nct05932472- Content hash
d87b70111127edc03b0900b6edcb5ee033feb2ddf15c637f2094654d66fc13c2